IP Verse

Corticosteroid Compositions - EP2214679B1

PatentPatent Analysis

EP2214679

MERITAGE PHARMA
Application Number
EP08850126A
Filing Date
Nov 12, 2008
Status
Revoked
Sep 24, 2021
Grant Date
Mar 27, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3574914B1
EP2585075B8
EP3354276B1

Bibliography

The patent EP2214679B1 was granted to Meritage Pharma on Mar 27, 2019 following the initial filing on Nov 12, 2008 under the application number EP08850126A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTERDec 27, 2019ADMISSIBLE
DR FALK PHARMADec 19, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents